Great post by KJT earlier.
I agree that Daybue sales have dampened the good run.
Lets not forget that John was very clear yesterday, that there is massive growth to come with Retts sufferers in North America.
And he said that the sales growth from the beginning has been fantastic. Or sentiment such as.
It would have been nice to get above the $22.50 line and consolidate and/or accelerate. But a quick rebound can be had.
And Angelman results won`t be far away. Does anyone here have many doubts about that trial result being a positive outcome?
Share Price, page-10332
-
- There are more pages in this discussion • 1,832 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |